Cassava Sciences Other Long Term Liabilities (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.05 -0.07 (-3.30%) USD | NASDAQ | Jan 13, 16:00

2.07 +0.02 (+0.98%) Pre-Market: 09:08

View Other Long Term Liabilities (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

cbdMD, Inc.	--
BioMarin Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade
Geron Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	--